Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 13083 | 10.735 |
09:34 ET | 857 | 10.8 |
09:36 ET | 2502 | 10.695 |
09:38 ET | 2378 | 10.715 |
09:39 ET | 3292 | 10.76 |
09:41 ET | 700 | 10.75 |
09:43 ET | 400 | 10.75 |
09:45 ET | 2600 | 10.78 |
09:48 ET | 12802 | 10.71 |
09:50 ET | 2768 | 10.75 |
09:52 ET | 200 | 10.77 |
09:54 ET | 736 | 10.765 |
09:56 ET | 5468 | 10.78 |
09:57 ET | 300 | 10.77 |
09:59 ET | 2837 | 10.78 |
10:01 ET | 1619 | 10.79 |
10:03 ET | 1000 | 10.745 |
10:06 ET | 3250 | 10.74 |
10:08 ET | 2543 | 10.66 |
10:10 ET | 700 | 10.64 |
10:12 ET | 1000 | 10.67 |
10:14 ET | 950 | 10.685 |
10:15 ET | 2175 | 10.73 |
10:17 ET | 300 | 10.78 |
10:19 ET | 100 | 10.8 |
10:21 ET | 2597 | 10.79 |
10:24 ET | 400 | 10.77 |
10:26 ET | 3572 | 10.77 |
10:28 ET | 1699 | 10.75 |
10:30 ET | 2144 | 10.75 |
10:32 ET | 1400 | 10.76 |
10:33 ET | 1595 | 10.77 |
10:35 ET | 346 | 10.78 |
10:37 ET | 1241 | 10.77 |
10:39 ET | 3150 | 10.745 |
10:42 ET | 4447 | 10.74 |
10:44 ET | 300 | 10.75 |
10:46 ET | 1897 | 10.76 |
10:48 ET | 1000 | 10.79 |
10:51 ET | 575 | 10.79 |
10:53 ET | 200 | 10.79 |
10:55 ET | 700 | 10.77 |
10:57 ET | 21880 | 10.74 |
11:00 ET | 5005 | 10.725 |
11:02 ET | 4162 | 10.68 |
11:04 ET | 1400 | 10.71 |
11:06 ET | 588 | 10.72 |
11:08 ET | 7127 | 10.73 |
11:09 ET | 2100 | 10.76 |
11:11 ET | 521 | 10.7524 |
11:13 ET | 808 | 10.78 |
11:15 ET | 100 | 10.78 |
11:18 ET | 3400 | 10.84 |
11:20 ET | 810 | 10.85 |
11:22 ET | 5510 | 10.86 |
11:24 ET | 1150 | 10.86 |
11:26 ET | 700 | 10.85 |
11:27 ET | 3994 | 10.82 |
11:29 ET | 4361 | 10.81 |
11:31 ET | 1200 | 10.85 |
11:33 ET | 3699 | 10.84 |
11:36 ET | 800 | 10.84 |
11:38 ET | 900 | 10.83 |
11:40 ET | 700 | 10.825 |
11:42 ET | 2026 | 10.83 |
11:44 ET | 1249 | 10.81 |
11:45 ET | 4911 | 10.865 |
11:47 ET | 300 | 10.87 |
11:49 ET | 25813 | 10.85 |
11:54 ET | 200 | 10.84 |
11:56 ET | 1400 | 10.82 |
11:58 ET | 500 | 10.8305 |
12:00 ET | 1771 | 10.82 |
12:02 ET | 2480 | 10.81 |
12:03 ET | 1524 | 10.81 |
12:05 ET | 564 | 10.8131 |
12:07 ET | 1880 | 10.81 |
12:09 ET | 2856 | 10.81 |
12:12 ET | 1420 | 10.805 |
12:14 ET | 7950 | 10.75 |
12:16 ET | 2992 | 10.76 |
12:18 ET | 850 | 10.75 |
12:20 ET | 5120 | 10.77 |
12:21 ET | 300 | 10.77 |
12:23 ET | 100 | 10.76 |
12:25 ET | 11632 | 10.79 |
12:27 ET | 600 | 10.79 |
12:30 ET | 705 | 10.7825 |
12:32 ET | 2691 | 10.75 |
12:34 ET | 6055 | 10.75 |
12:36 ET | 1210 | 10.75 |
12:38 ET | 1000 | 10.77 |
12:41 ET | 100 | 10.78 |
12:43 ET | 858 | 10.78 |
12:45 ET | 1700 | 10.765 |
12:48 ET | 504 | 10.765 |
12:50 ET | 1903 | 10.76 |
12:52 ET | 100 | 10.75 |
12:54 ET | 200 | 10.75 |
12:56 ET | 771 | 10.75 |
12:57 ET | 1200 | 10.76 |
12:59 ET | 100 | 10.76 |
01:01 ET | 200 | 10.76 |
01:03 ET | 5219 | 10.75 |
01:06 ET | 2700 | 10.745 |
01:10 ET | 981 | 10.755 |
01:12 ET | 1075 | 10.775 |
01:14 ET | 200 | 10.775 |
01:17 ET | 1700 | 10.77 |
01:19 ET | 5103 | 10.77 |
01:21 ET | 826 | 10.765 |
01:24 ET | 2300 | 10.75 |
01:26 ET | 700 | 10.745 |
01:28 ET | 200 | 10.745 |
01:30 ET | 6048 | 10.695 |
01:32 ET | 4102 | 10.71 |
01:35 ET | 322 | 10.72 |
01:37 ET | 100 | 10.71 |
01:39 ET | 1800 | 10.72 |
01:42 ET | 408 | 10.72 |
01:44 ET | 1000 | 10.72 |
01:46 ET | 400 | 10.715 |
01:48 ET | 3550 | 10.7 |
01:50 ET | 500 | 10.7 |
01:51 ET | 400 | 10.705 |
01:53 ET | 2357 | 10.6847 |
01:55 ET | 809 | 10.695 |
01:57 ET | 400 | 10.69 |
02:00 ET | 446 | 10.69 |
02:02 ET | 515 | 10.69 |
02:04 ET | 400 | 10.69 |
02:06 ET | 1873 | 10.72 |
02:08 ET | 400 | 10.725 |
02:09 ET | 705 | 10.725 |
02:11 ET | 852 | 10.73 |
02:13 ET | 1245 | 10.715 |
02:15 ET | 101 | 10.715 |
02:18 ET | 900 | 10.71 |
02:20 ET | 2122 | 10.69 |
02:22 ET | 400 | 10.68 |
02:24 ET | 400 | 10.67 |
02:26 ET | 2200 | 10.69 |
02:27 ET | 200 | 10.68 |
02:29 ET | 1103 | 10.695 |
02:31 ET | 2014 | 10.72 |
02:33 ET | 800 | 10.715 |
02:36 ET | 400 | 10.725 |
02:38 ET | 1200 | 10.725 |
02:40 ET | 3927 | 10.735 |
02:42 ET | 3767 | 10.775 |
02:44 ET | 2554 | 10.81 |
02:45 ET | 300 | 10.81 |
02:47 ET | 6202 | 10.78 |
02:49 ET | 712 | 10.785 |
02:51 ET | 1122 | 10.79 |
02:54 ET | 749 | 10.79 |
02:56 ET | 2882 | 10.805 |
02:58 ET | 537 | 10.805 |
03:00 ET | 3129 | 10.755 |
03:02 ET | 1643 | 10.75 |
03:03 ET | 1791 | 10.76 |
03:05 ET | 200 | 10.765 |
03:07 ET | 1000 | 10.775 |
03:09 ET | 100 | 10.775 |
03:12 ET | 429 | 10.775 |
03:14 ET | 3285 | 10.78 |
03:16 ET | 800 | 10.785 |
03:18 ET | 894 | 10.78 |
03:20 ET | 1007 | 10.78 |
03:21 ET | 2026 | 10.76 |
03:23 ET | 3212 | 10.77 |
03:25 ET | 400 | 10.79 |
03:27 ET | 1799 | 10.78 |
03:30 ET | 1934 | 10.77 |
03:32 ET | 1521 | 10.795 |
03:34 ET | 1260 | 10.795 |
03:36 ET | 1626 | 10.795 |
03:38 ET | 2714 | 10.82 |
03:39 ET | 907 | 10.805 |
03:41 ET | 1002 | 10.8 |
03:43 ET | 1401 | 10.805 |
03:45 ET | 3400 | 10.815 |
03:48 ET | 700 | 10.815 |
03:50 ET | 2652 | 10.815 |
03:52 ET | 6053 | 10.81 |
03:54 ET | 4914 | 10.79 |
03:56 ET | 10110 | 10.77 |
03:57 ET | 18197 | 10.755 |
03:59 ET | 143376 | 10.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.5B | -2.7x | --- |
Arcus Biosciences Inc | 1.4B | -5.1x | --- |
Immatics NV | 1.2B | -11.0x | --- |
Ardelyx Inc | 1.6B | -23.9x | --- |
Prothena Corporation PLC | 1.1B | -6.1x | --- |
Silence Therapeutics PLC | 1.0B | -17.9x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | 18.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.